Association between sex hormones and anti-S/RBD antibody responses to COVID-19 vaccines in healthcare workers

References

• World Health Organization. Health and care worker deaths during COVID-19. Geneva (CH); 2021 Oct 20 [accessed May 11 2023]. https://www.who.int/news/item/20-10-2021-health-and-care-worker-deaths-during-covid-19.
   Google Scholar
• World Health Organization. WHO and partners call for action to better protect health and care workers from COVID-19. Geneva (CH); 2021 Oct 21 [accessed May 11 2023]. https://www.who.int/news/item/21-10-2021-who-and-partners-call-for-action-to-better-protect-health-and-care-workers-from-covid-19.
   Google Scholar
• Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, Meyers LA, Neuzil KM, Langley JM, Fitzpatrick MC, et al. The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States. Clin Infect Dis. 2021;73(12):2257–9. doi:10.1093/cid/ciab079. PMID: 33515252.
   PubMed Web of Science ®Google Scholar
• Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293–302. doi:10.1016/S1473-3099(22)00320-6. PMID: 35753318.
   PubMed Web of Science ®Google Scholar
• Yang H, Rao Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol. 2021;19(11):685–700. doi:10.1038/s41579-021-00630-8. PMID: 34535791.
   PubMed Web of Science ®Google Scholar
• Min L, Sun Q. Antibodies and vaccines target RBD of SARS-CoV-2. Front Mol Biosci. 2021;8:671633. doi:10.3389/fmolb.2021.671633. PMID: 33968996.
   PubMed Web of Science ®Google Scholar
• Krammer F. A correlate of protection for SARS-CoV-2 vaccines is urgently needed. Nat Med. 2021;27(7):1147–8. doi:10.1038/s41591-021-01432-4. PMID: 34239135.
   PubMed Web of Science ®Google Scholar
• Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205–11. doi:10.1038/s41591-021-01377-8. PMID: 34002089.
   PubMed Web of Science ®Google Scholar
• Lustig Y, Sapir E, Regev-Yochay G, Cohen C, Fluss R, Olmer L, Indenbaum V, Mandelboim M, Doolman R, Amit S, et al. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lancet Respir Med. 2021;9(9):999–1009. doi:10.1016/S2213-2600(21)00220-4. PMID: 34224675.
   PubMed Web of Science ®Google Scholar
• Gilbert PB, Donis RO, Koup RA, Fong Y, Plotkin SA, Follmann D. A covid-19 milestone attained - a correlate of protection for vaccines. N Engl J Med. 2022;387(24):2203–6. doi:10.1056/NEJMp2211314. PMID: 36507702.
   PubMed Web of Science ®Google Scholar
• Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, Dull P, Plotkin SA. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021;39(32):4423–8. doi:10.1016/j.vaccine.2021.05.063. PMID: 34210573.
   PubMed Web of Science ®Google Scholar
• Lo Sasso B, Agnello L, Giglio RV, Gambino CM, Ciaccio AM, Vidali M, Ciaccio M. Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine. Sci Rep. 2022;12(1):8679. doi:10.1038/s41598-022-12750-z. PMID: 35606426.
   PubMed Web of Science ®Google Scholar
• Crawford KHD, Dingens AS, Eguia R, Wolf CR, Wilcox N, Logue JK, Shuey K, Casto AM, Fiala B, Wrenn S, et al. Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;223(2):197–205. doi:10.1093/infdis/jiaa618. PMID: 33535236.
   PubMed Web of Science ®Google Scholar
• Jo DH, Minn D, Lim J, Lee KD, Kang YM, Choe KW, Kim KN. Rapidly declining SARS-CoV-2 antibody titers within 4 months after BNT162b2 vaccination. Vaccines (Basel). 2021;9(10):1145. doi:10.3390/vaccines9101145. PMID: 34696253.
   PubMed Web of Science ®Google Scholar
• Flanagan KL, Fink AL, Plebanski M, Klein SL. Sex and Gender differences in the outcomes of vaccination over the life course. Annu Rev Cell Dev Biol. 2017;33(1):577–99. doi:10.1146/annurev-cellbio-100616-060718. PMID: 28992436.
   PubMed Web of Science ®Google Scholar
• Jacobsen H, Klein SL. Sex differences in immunity to viral infections. Front Immunol. 2021;12:720952. doi:10.3389/fimmu.2021.720952. PMID: 34531867.
   PubMed Web of Science ®Google Scholar
• Ciarambino T, Barbagelata E, Corbi G, Ambrosino I, Politi C, Lavalle F, Ruggieri A, Moretti A. Gender differences in vaccine therapy: where are we in COVID-19 pandemic? Monaldi Arch Chest Dis. 2021;91(4). doi:10.4081/monaldi.2021.1669. PMID: 33840183.
   PubMed Web of Science ®Google Scholar
• Anastassopoulou C, Antoni D, Manoussopoulos Y, Stefanou P, Argyropoulou S, Vrioni G, Tsakris A, Fast PE. Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: a mixed effects model across two vaccination periods. PloS One. 2022;17(4):e0266958. doi:10.1371/journal.pone.0266958. PMID: 35486622.
   PubMed Web of Science ®Google Scholar
• Ward H, Whitaker M, Flower B, Tang SN, Atchison C, Darzi A, Donnelly CA, Cann A, Diggle PJ, Ashby D, et al. Population antibody responses following COVID-19 vaccination in 212,102 individuals. Nat Commun. 2022;13(1):907. doi:10.1038/s41467-022-28527-x. PMID: 35173150.
   PubMed Web of Science ®Google Scholar
• Jensen A, Stromme M, Moyassari S, Chadha AS, Tartaglia MC, Szoeke C, Ferretti MT. COVID-19 vaccines: considering sex differences in efficacy and safety. Contemp Clin Trials. 2022;115:106700. doi:10.1016/j.cct.2022.106700. PMID: 35149232.
   PubMed Web of Science ®Google Scholar
• Shapira G, Abu Hamad R, Weiner C, Rainy N, Sorek-Abramovich R, Benveniste-Levkovitz P, Rock R, Avnat E, Levtzion-Korach O, Bar Chaim A, et al. Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccination. FASEB J. 2022;36(4):e22223. doi:10.1096/fj.202101492R. PMID: 35239233.
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Curtis N. Factors that influence the immune response to vaccination. Clin Microbiol Rev. 2019;32(2):e00084–18. doi:10.1128/CMR.00084-18. PMID: 30867162.
   PubMed Web of Science ®Google Scholar
• Fathi A, Addo MM, Dahlke C. Sex differences in immunity: implications for the development of novel vaccines against emerging pathogens. Front Immunol. 2021;11:601170. doi:10.3389/fimmu.2020.601170. PMID: 33488596.
   PubMed Web of Science ®Google Scholar
• Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 2019;41(2):239–49. doi:10.1007/s00281-018-0726-5. PMID: 30547182.
   PubMed Web of Science ®Google Scholar
• Marchevsky NG, Li G, Aley P, Costa Clemens SA, Barrett JR, Belij-Rammerstorfer S, Bibi S, Clutterbuck E, Dold C, Felle S, et al. An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females. EBioMedicine. 2022;81:104128. doi:10.1016/j.ebiom.2022.104128. PMID: 35779491.
   PubMed Web of Science ®Google Scholar
• Lustig Y, Gonen T, Meltzer L, Gilboa M, Indenbaum V, Cohen C, Amit S, Jaber H, Doolman R, Asraf K, et al. Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose. Nat Immunol. 2022;23(6):940–6. doi:10.1038/s41590-022-01212-3. PMID: 35534723.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Oshiro Y, Inamura N, Nemoto T, Horii K, Okudera K, Konishi M, Ozeki M, Mizoue T, Sugiyama H, et al. Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine. Clin Microbiol Infect. 2023;29(9):e1201.1–e15. doi:10.1016/j.cmi.2023.05.020. PMID: 37236545.
   Web of Science ®Google Scholar
• Müller L, Andrée M, Moskorz W, Drexler I, Walotka L, Grothmann R, Ptok J, Hillebrandt J, Ritchie A, Rabl D, et al. Age-dependent immune response to the Biontech/Pfizer BNT162b2 coronavirus disease 2019 vaccination. Clin Infect Dis. 2021;73(11):2065–72. doi:10.1093/cid/ciab381. PMID: 33906236.
   PubMed Web of Science ®Google Scholar
• Newman J, Thakur N, Peacock TP, Bialy D, Elrefaey AME, Bogaardt C, Horton DL, Ho S, Kankeyan T, Carr C, et al. Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2. Nature Microbiology. 2022;7(8):1180–8. doi:10.1038/s41564-022-01163-3. PMID: 35836002.
   PubMed Web of Science ®Google Scholar
• Hägg S, Religa D. COVID vaccination in older adults. Nature Microbiology. 2022;7(8):1106–7. doi:10.1038/s41564-022-01166-0. PMID: 35836001.
   PubMed Web of Science ®Google Scholar
• Naaber P, Tserel L, Kangro K, Sepp E, Jürjenson V, Adamson A, Haljasmägi L, Rumm AP, Maruste R, Kärner J, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet Reg Health Eur. 2021;10:100208. doi:10.1016/j.lanepe.2021.100208. PMID: 34514454.
   PubMedGoogle Scholar
• Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, Doolman R, Asraf K, Mendelson E, Ziv A, et al. Waning immune humoral response to BNT162b2 covid-19 vaccine over 6 months. N Engl J Med. 2021;385(24):e84. doi:10.1056/NEJMoa2114583. PMID: 34614326; PMCID: PMC8522797.
   PubMed Web of Science ®Google Scholar
• Wheatley AK, Juno JA, Wang JJ, Selva KJ, Reynaldi A, Tan HX, Lee WS, Wragg KM, Kelly HG, Esterbauer R, et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021;12(1):1162. doi:10.1038/s41467-021-21444-5. PMID: 33608522.
   PubMed Web of Science ®Google Scholar
• Terreri S, Piano Mortari E, Vinci MR, Russo C, Alteri C, Albano C, Colavita F, Gramigna G, Agrati C, Linardos G, et al. Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections. Cell Host & Microbe. 2022;30(3):400–8.e4. doi:10.1016/j.chom.2022.01.003. PMID: 35134333.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Iwasaki A. Sex differences in immune responses. Sci. 2021;371(6527):347–8. doi:10.1126/science.abe7199. PMID: 33479140.
   PubMed Web of Science ®Google Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38. doi:10.1038/nri.2016.90. PMID: 27546235.
   PubMed Web of Science ®Google Scholar
• Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015;14(3):309–21. doi:10.1111/acel.12326. PMID: 25720438.
   PubMed Web of Science ®Google Scholar
• Harding AT, Heaton NS. The impact of estrogens and their receptors on immunity and inflammation during infection. Cancers Basel. 2022;14(4):909. doi:10.3390/cancers14040909. PMID: 35205657.
   PubMed Web of Science ®Google Scholar
• Potluri T, Fink AL, Sylvia KE, Dhakal S, Vermillion MS, Vom Steeg L, Deshpande S, Narasimhan H, Klein SL. Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. NPJ Vaccines. 2019;4(1):29. doi:10.1038/s41541-019-0124-6. PMID: 31312529.
   PubMedGoogle Scholar
• Dupuis ML, Maselli A, Pagano MT, Pierdominici M, Ortona E. Immune response and autoimmune diseases: a matter of sex. Ital J Gender-Specific Med. 2019;5(1):11–20. doi:10.1723/3148.31294.
   Google Scholar
• Mohamad NV, Wong SK, Wan Hasan WN, Jolly JJ, Nur-Farhana MF, Ima-Nirwana S, Chin KY. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2019;22(2):129–40. doi:10.1080/13685538.2018.1482487. PMID: 29925283.
   PubMed Web of Science ®Google Scholar
• Gubbels Bupp MR, Jorgensen TN. Androgen-Induced Immunosuppression. Front Immunol. 2018;9:794. doi:10.3389/fimmu.2018.00794. PMID: 29755457.
   PubMed Web of Science ®Google Scholar
• Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiébaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A. 2014;111(2):869–74. doi:10.1073/pnas.1321060111. PMID: 24367114.
   PubMed Web of Science ®Google Scholar
• Nowak J, Pawłowski B, Borkowska B, Augustyniak D, Drulis-Kawa Z. No evidence for the immunocompetence handicap hypothesis in male humans. Sci Rep. 2018;8(1):7392. doi:10.1038/s41598-018-25694-0. PMID: 29743556.
   PubMedGoogle Scholar
• Rantala MJ, Moore FR, Skrinda I, Krama T, Kivleniece I, Kecko S, Krams I. Evidence for the stress-linked immunocompetence handicap hypothesis in humans. Nat Commun. 2012;3(1):694. doi:10.1038/ncomms1696. PMID: 22353724.
   PubMedGoogle Scholar
• Vottero A, Rochira V, Capelletti M, Viani I, Zirilli L, Neri TM, Carani C, Bernasconi S, Ghizzoni L. Aromatase is differentially expressed in peripheral blood leukocytes from children, and adult female and male subjects. Eur J Endocrinol. 2006;154(3):425–31. doi:10.1530/eje.1.02102. PMID: 16498056.
   PubMed Web of Science ®Google Scholar
• Surman SL, Jones BG, Penkert RR, Sealy RE, Marion T, Thomas PG, Neale G, Xu B, Hurwitz JL. How estrogen, testosterone, and sex differences influence serum immunoglobulin isotype patterns in mice and humans. Viruses. 2023;15(2):482. doi:10.3390/v15020482. PMID: 36851695.
   PubMed Web of Science ®Google Scholar
• Butts CL, Jones YL, Lim JK, Salter CE, Belyavskaya E, Sternberg EM. Tissue expression of steroid hormone receptors is associated with differential immune responsiveness. Brain Behav Immun. 2011;25(5):1000–7. doi:10.1016/j.bbi.2010.11.003. PMID: 21074604.
   PubMed Web of Science ®Google Scholar